Skip to main content
Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · IEX Real-Time Price · USD
0.480
+0.022 (4.80%)
At close: May 1, 2024, 1:37 PM
0.439
-0.041 (-8.56%)
After-hours: May 1, 2024, 5:00 PM EDT

Evoke Pharma Revenue

In the year 2023, Evoke Pharma had annual revenue of $5.18M with 106.51% growth. Revenue in the quarter ending December 31, 2023 was $1.68M with 110.45% year-over-year growth.

Revenue (ttm)
$5.18M
Revenue Growth
+106.51%
P/S Ratio
0.79
Revenue / Employee
$1,295,158
Employees
4
Market Cap
4.07M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.18M2.67M106.51%
Dec 31, 20222.51M890.57K55.04%
Dec 31, 20211.62M1.60M6,929.00%
Dec 31, 202023.02K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Dec 31, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

EVOK News

More News